Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China

In retrospective case series (n=214), neurologic manifestations (NMs) were common in patients with COVID-19 (78/214 [36.4%]). Authors suggest clinicians should suspect severe acute respiratory syndrome coronavirus 2 infection as a differential diagnosis in patients with NMs.

SPS commentary:

According to an editorial, it is clear that this small series does not reflect the entire spectrum of neurologic disease in COVID-19 disease, and much is left to be learned with thorough neurologic testing in large data sets of patients with COVID-19. It suggests that as the means for reliably assessing infection and prior exposure become available, less common neurologic complications should be anticipated.


JAMA Neurology

Resource links: